No Data
Altimmune Shares Surge on CEO's CNBC Appearance
Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday
Altimmune Stock Up More Than 25% in a Month: Here's Why
Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders
Express News | US weight loss drug concept stocks rose across the board, with Viking Therapeutics up more than 5%, Altimmune and Eli Lilly and Co up more than 3%, Sorrento Biologicals and Novo-Nordisk A/S up more than 2%. Previously, US President Biden proposed medical
Amgen (AMGN.US) releases mid-term data for weight loss therapy MariTide, with weight loss results comparable to Novartis.
Amgen announced on Tuesday that its experimental weight loss therapy MariTide has achieved significant results in Phase 2 trials.
No Data
No Data
